Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib.
about
Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib.Identifying and validating a combined mRNA and microRNA signature in response to imatinib treatment in a chronic myeloid leukemia cell line.Whole-exome sequencing of a rare case of familial childhood acute lymphoblastic leukemia reveals putative predisposing mutations in Fanconi anemia genesTargeting mutated tyrosine kinases in the therapy of myeloid leukaemias.Molecular classification and pathogenesis of eosinophilic disorders: 2005 update.Modern diagnosis and treatment of primary eosinophilia.Myeloproliferative disorders: the centrosome connection.Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical developmentEosinophilia: secondary, clonal and idiopathic.Fusion of platelet-derived growth factor receptor β to CEV14 gene in chronic myelomonocytic leukemia: A case report and review of the literature.Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1.Molecular diagnosis of myeloproliferative neoplasms.Validating cancer drug targets through chemical geneticsAdvances in molecular diagnostics of myeloproliferative disorders.Neuroendocrine Merkel cell carcinoma is associated with mutations in key DNA repair, epigenetic and apoptosis pathways: a case-based study using targeted massively parallel sequencingPDGFRB gain-of-function mutations in sporadic infantile myofibromatosis.PDGFRᵝ-Rearranged Myeloid Neoplasm with Marked Eosinophilia in a 37-Year-Old Man; And a Literature Review.Centrosomal targeting of tyrosine kinase activity does not enhance oncogenicity in chronic myeloproliferative disorders.A Rare Case of Extramedullary T/Myeloid Mixed Phenotype Acute Leukemia with t(1;5)(q23;q33).Cytogenetic studies of Brazilian pediatric myelodysplastic syndrome cases: challenges and difficulties in a large and emerging countryKIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32).Imatinib-responsive hypereosinophilia in a patient with B cell ALL.Molecular diagnosis and targeted therapy of a pediatric chronic eosinophilic leukemia patient carrying TPM3-PDGFRB fusion.Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics.Molecular analysis of PDGFRalpha/beta genes in core binding factor leukemia with eosinophilia.Idiopathic hypereosinophilia is clonal disorder? Clonality identified by targeted sequencing.Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.Fusion of PDGFRB to MPRIP, CPSF6, and GOLGB1 in three patients with eosinophilia-associated myeloproliferative neoplasms.Congenital and childhood myeloproliferative disorders with eosinophilia responsive to imatinib.Chronic myeloproliferative disorder with ETV6-PDGFRβ fusion gene.Rare gene fusion rearrangement SPTNB1-PDGFRB in an atypical myeloproliferative neoplasm
P2860
Q33718814-DA0E7BA0-C479-4200-A077-EE3D3BBE0550Q34703835-8B839E90-87FE-40F2-B325-6A2705F288D1Q35706511-251BD2E3-9D4D-40B1-BE41-787314ED22F3Q35782893-468419C7-71F8-4CE8-A068-E8C2DDF59256Q36182741-79EAE68F-23FE-459C-8DE5-CB4EE1C723EFQ36182754-FCB3052A-1A2D-447B-B5AB-5EFA14A34650Q36233843-14032EAA-7323-48DB-A7B9-6D64FF481438Q36299617-4CCB3461-5AA7-40D8-81D2-2E8EF2A7BBA9Q36471689-167146D2-EB73-45C3-B3E3-327AED63DFE9Q36502974-D04E5BDF-37A5-43AD-B2DE-A3C887A8C855Q37379320-797B5119-1102-4359-918A-B1807BC1BBF4Q37542270-3AA104FB-536B-4C80-BEB2-62A5EF0DAC61Q37779884-7A25A373-45DA-4043-93AB-656371310BD5Q38089228-D0F5FC68-9460-47B1-A95C-7ADBB7124610Q38388671-90D6C1AC-3FC5-4F7F-B9EB-CC85C4921999Q38882182-84E9C4E7-64CE-4308-A2A8-B06C1C8429B5Q39139762-E75505A0-4DAD-4EA1-8D66-F9F5B3464926Q39455159-7FD146A4-AE4F-4538-B1B9-E97B1171AC2FQ40973915-B37A6319-520B-44DA-A8D9-2A0CEE131108Q41886704-139E5EB1-360A-4944-A60E-77647F7AA07BQ45117346-C0E235AF-4708-4BB5-8944-91D6E5B95524Q45204134-19E09624-D469-47D0-A84D-198E0A47252DQ45371820-A9A9AC77-CCC8-4151-98B9-A49ECCFE88C0Q46384943-F638B7B2-0E5A-4F70-B60C-FB4D3B74C612Q46846861-5188AA5D-97EC-4D79-ACF5-1D0F32F9072CQ47114619-D9371A89-F5C2-42FE-94B4-873316FC3977Q52569224-82312AC4-86F8-44DC-8470-55A9EE1E966BQ53350377-087561F8-40F3-4925-A17E-5BA6FE3762B5Q54518482-FCE2FC7B-4330-4236-834D-3767980B0B8AQ54568493-CCD0DE57-1724-4629-B47B-4AF74FA0A4D3Q58121098-5CED3E7B-5980-43E4-A60F-A01D39D975DE
P2860
Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Cloning of the t
@nl
Cloning of the t(1;5)(q23;q33) ...... GFRB and response to imatinib.
@en
type
label
Cloning of the t
@nl
Cloning of the t(1;5)(q23;q33) ...... GFRB and response to imatinib.
@en
prefLabel
Cloning of the t
@nl
Cloning of the t(1;5)(q23;q33) ...... GFRB and response to imatinib.
@en
P2093
P1433
P1476
Cloning of the t(1;5)(q23;q33) ...... GFRB and response to imatinib.
@en
P2093
Charles Lee
Elvira R P Velloso
Jon C Aster
Kathryn Wilkinson
Luiz Fernando Lopes
Margaret A Shipp
Ricardo C T Aguiar
P304
P356
10.1182/BLOOD-2003-04-1150
P407
P577
2003-08-07T00:00:00Z